(Q39127090)

9 September 2017

title

Curcumin enhances TRAIL-induced apoptosis of breast cancer cells by regulating apoptosis-related proteins (English)

1 reference

9 September 2017

0 references

1 reference

Sojung Park

1

1 reference

9 September 2017

Dong Hyung Cho

2

1 reference

9 September 2017

Ladislav Andera

3

1 reference

9 September 2017

Nayoung Suh

4

1 reference

9 September 2017

Inki Kim

5

1 reference

9 September 2017

publication date

12 July 2013

1 reference

Molecular and Cellular Biochemistry

9 September 2017

published in

1 reference

9 September 2017

volume

383

1 reference

9 September 2017

issue

1-2

1 reference

9 September 2017

page(s)

39-48

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-013-1752-1

9 September 2017

exact match

0 references

cites work

Curcumin as "Curecumin": from kitchen to clinic.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Curcumin: the story so far.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Neuroprotective effects of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

A potential role of the curry spice curcumin in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Targeting death receptors in cancer with Apo2L/TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

TRAIL receptor signalling and modulation: Are we on the right TRAIL?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Protein kinase C epsilon confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

MS-275 sensitizes TRAIL-resistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Therapeutic efficacy of curcumin/TRAIL combination regimen for hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Downregulation of Mcl-1 by daunorubicin pretreatment reverses resistance of breast cancer cells to TNF-related apoptosis-inducing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Targeting the phosphoinositide 3-kinase pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Mcl-1: a gateway to TRAIL sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

mir-29 regulates Mcl-1 protein expression and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

The Akt-mTOR tango and its relevance to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Role of PI3K/Akt signaling in TRAIL- and radiation-induced gastrointestinal apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Modulation of curcumin-induced Akt phosphorylation and apoptosis by PI3K inhibitor in MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Acquired TRAIL resistance in human breast cancer cells are caused by the sustained cFLIP(L) and XIAP protein levels and ERK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1752-1

Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecan

21 January 2018

1 reference

12 December 2020

Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.

1 reference

12 December 2020

Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines.

1 reference

12 December 2020

Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation

1 reference

12 December 2020

Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria.

1 reference

12 December 2020

10.1007/S11010-013-1752-1

Identifiers

DOI

1 reference

9 September 2017

1 reference